MedTrace Logo

Pharmacological Intervention in Depression After Traumatic Brain Injury

NCT00205491 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2017-03-17

No results posted yet for this study

Summary

The purpose of this study is to determine if treatment with venlafaxine reduces symptoms of depression in persons with traumatic brain injury.

Conditions

  • TBI (Traumatic Brain Injury)

Interventions

DRUG

Venlafaxine

Sponsors & Collaborators

  • U.S. Department of Education

    collaborator FED

  • Virginia Commonwealth University

    lead OTHER

Principal Investigators

  • Jeffrey S. Kreutzer, PhD · Virginia Commonwealth University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-10-31
Primary Completion
2007-09-30
Completion
2007-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00205491 on ClinicalTrials.gov